Clinical Trials Directory

Trials / Completed

CompletedNCT04795804

Human Milk Oligossaccharide and Acetate Production in Vivo

The Effects of Human-like Milk Oligosaccharide and Resistant Starch on Acetate Production and Human Substrate Metabolism

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
Male
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

The study investigators hypothesize (1) that the SCFA/acetate metabolism differs between metabolic phenotypes and (2) that using a mixture of fibres that differ in degree of polymerization and branching namely a resistant starch and a human-like milk oligosaccharide enhance the acetate availability in the distal colon and systemic circulation, consequently leading to its metabolic effects. To study this, the investigators will supplement lean, normoglycaemic vs. overweight/obese, prediabetic men with the fibre mixture the day before the clinical investigation day (CID) and study during the CID its effects on fasting and postprandial substrate and energy metabolism.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHuman Milk OligossaccharideThe day before the CIDs, the participants receive the supplements 3x a day in randomized order
DIETARY_SUPPLEMENTMaltodextrinThe day before the CIDs, the participants receive the supplements 3x a day in randomized order
DIETARY_SUPPLEMENTHuman Milk Oligossaccharide and resistant starchThe day before the CIDs, the participants receive the supplements 3x a day in randomized order

Timeline

Start date
2020-02-04
Primary completion
2021-10-15
Completion
2021-10-15
First posted
2021-03-12
Last updated
2021-11-03

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04795804. Inclusion in this directory is not an endorsement.